Netflix initiated, Palantir upgraded: Wall Street's top analyst calls

Core Viewpoint - The article discusses recent initiations of coverage by various financial institutions on several companies, highlighting their ratings and price targets, as well as the strategic insights behind these ratings. Group 1: Netflix (NFLX) - HSBC initiated coverage with a Buy rating and a price target of $107, citing Netflix's acquisitions as a response to challenges in a maturing video streaming industry, and labeling it the "undisputed global streaming leader" [1]. Group 2: Medline (MDLN) - Barclays initiated coverage with an Overweight rating and a price target of $50, emphasizing the company's scale, private-label differentiation, and logistics capabilities. Multiple firms including Wolfe Research, JPMorgan, and Goldman Sachs also started coverage with Buy-equivalent ratings, while Deutsche Bank and Wells Fargo initiated with Neutral-equivalent ratings [1]. Group 3: Andersen Group (ANDG) - Baird initiated coverage with an Outperform rating and a price target of $40, describing the company as a "highly differentiated premium provider" of tax, valuation, and advisory services. UBS and Deutsche Bank also initiated with Buy-equivalent ratings, while Morgan Stanley and Wells Fargo provided Neutral-equivalent ratings [1]. Group 4: Rocket Companies (RKT) - JPMorgan reinstated coverage with a Neutral rating and a price target of $24, expressing a constructive view on the company's new strategy but suggesting that investors may have already priced in lower rate scenarios and market share gains from acquisitions [1]. Group 5: Hims & Hers (HIMS) - Evercore ISI initiated coverage with an In Line rating and a price target of $33, viewing the current valuation as "reasonable" while noting that the market may be underestimating the durability and diversity of Hims' core platform [1].